The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia.
 
Mahran Shoukier
No Relationships to Disclose
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie; Cellectis; Genentech/Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Stemline Therapeutics (Inst)
 
Courtney Denton Dinardo
Honoraria - Abbvie; Agios; Bayer; Celgene; Karyopharm Therapeutics; MedImmune
Consulting or Advisory Role - Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Farhad Ravandi
Honoraria - Amgen; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amgen; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen Astellas BioPharma; Bristol-Myers Squibb (Mexico); Merck Animal Health; Seagen; Sunesis Pharmaceuticals
 
Michael Andreeff
Stock and Other Ownership Interests - Aptose Biosciences; Eutropics; Oncoceutics; Oncolyze; Reata Pharmaceuticals; Senti Biosciences
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals
Research Funding - Amgen; AstraZeneca; Breast Cancer Research Foundation; CPRIT; Daiichi Sankyo; Karyopharm Therapeutics; NIH/NCI; Ono Pharmaceutical; United Therapeutics
Patents, Royalties, Other Intellectual Property - Patent with Reata
Travel, Accommodations, Expenses - Amgen; Aptose Biosciences; AstraZeneca; Oncoceutics
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals
Research Funding - Astex Pharmaceuticals; celgene
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Naval Guastad Daver
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Nohla Therapeutics; Pfizer; Servier
 
Gautam Borthakur
No Relationships to Disclose
 
Naveen Pemmaraju
Honoraria - Celgene; Incyte; LFB Biotechnologies; Novartis; Stemline Therapeutics
Consulting or Advisory Role - Celgene; Incyte; LFB Biotechnologies; Novartis; Stemline Therapeutics
Research Funding - Abbvie; Affymetrix/Thermo Fisher Scientific; Cellectis; Daiichi Sankyo; Incyte; Novartis; Plexxikon; Samus Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Celgene; mustangbio; Stemline Therapeutics
 
Guillermo Montalban-Bravo
No Relationships to Disclose
 
Christopher Brent Benton
No Relationships to Disclose
 
Nicholas James Short
No Relationships to Disclose
 
Kapil N. Bhalla
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Tapan M. Kadia
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Sanofi